These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9502390)
41. Investigation of regional glutathione levels in a model of chemically-induced renal papillary necrosis. Lenz SD Food Chem Toxicol; 1996 May; 34(5):489-94. PubMed ID: 8655099 [TBL] [Abstract][Full Text] [Related]
42. Urinary lipid changes during the development of chemically-induced renal papillary necrosis: a study using mefenamic acid and N-phenylanthranilic acid. T K Thanh Greg Stevenson David K Obatomi Berhnard Aicher Manfred Baumeister Peter H Bach N Biomarkers; 2001; 6(6):417-27. PubMed ID: 23886313 [TBL] [Abstract][Full Text] [Related]
43. High resolution light microscopic morphological and microvascular changes in an acutely induced renal papillary necrosis. Gregg NJ; Courtauld EA; Bach PH Toxicol Pathol; 1990; 18(1 Pt 1):47-55. PubMed ID: 2194275 [TBL] [Abstract][Full Text] [Related]
44. Nephrotoxicities of nonsteroidal anti-inflammatory drugs. Wen SF J Formos Med Assoc; 1997 Mar; 96(3):157-71. PubMed ID: 9080753 [TBL] [Abstract][Full Text] [Related]
45. The metabolism of 2-bromo-[1-14C]ethan-1-amine (BEA): a model compound for inducing renal papillary necrosis (RPN). Bach PH; Christian R; Baker J; Bridges JW Dev Toxicol Environ Sci; 1980; 8():533-6. PubMed ID: 7308055 [No Abstract] [Full Text] [Related]
46. [Adverse kidney effects of nonsteroidal anti-inflammatory agents-- current physiopathological and clinical aspects]. Duţu A; Parasca I Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(5):405-14. PubMed ID: 2894058 [No Abstract] [Full Text] [Related]
47. Pattern of renal cortical scarring after experimental papillary necrosis. Whitbourn RJ; Henry MA; Tange JD Pathology; 1984 Jul; 16(3):272-7. PubMed ID: 6514395 [TBL] [Abstract][Full Text] [Related]
48. Necrosis in situ: a form of renal papillary necrosis seen in analgesic nephropathy. Poynter JD; Hare WS Radiology; 1974 Apr; 111(1):69-76. PubMed ID: 4816121 [No Abstract] [Full Text] [Related]
54. Over-the-counter analgesic use. De Broe ME; Elseviers MM J Am Soc Nephrol; 2009 Oct; 20(10):2098-103. PubMed ID: 19423685 [TBL] [Abstract][Full Text] [Related]
55. Pathogenesis of the renal lesion associated with the abuse of analgesics. Kincaid-Smith P Lancet; 1967 Apr; 1(7495):859-62. PubMed ID: 4164364 [No Abstract] [Full Text] [Related]
56. Relevance of animal models to analgesic-associated renal papillary necrosis in humans. Bach PH; Hardy TL Kidney Int; 1985 Oct; 28(4):605-13. PubMed ID: 3910912 [No Abstract] [Full Text] [Related]
57. [Renal tolerance of selective inhibitors of cyclooxygenase type 2]. Deray G Presse Med; 2001 Oct; 30(30):1507-12. PubMed ID: 11712212 [TBL] [Abstract][Full Text] [Related]
58. Chronic renal lesions in the uninephrectomized Gunn rat after analgesic mixtures. Henry MA; Tange JD Pathology; 1984 Jul; 16(3):278-84. PubMed ID: 6514396 [TBL] [Abstract][Full Text] [Related]
59. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system. Auriel E; Regev K; Korczyn AD Handb Clin Neurol; 2014; 119():577-84. PubMed ID: 24365321 [TBL] [Abstract][Full Text] [Related]
60. Nephrotoxicity of nonsteroidal anti-inflammatory drugs. Khokhar N Am Fam Physician; 1984 Jul; 30(1):123-8. PubMed ID: 6464946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]